发明名称 GENETIC POLYMORPHISMS ASSOCIATED WITH CARDIOVASCULAR DISORDERS AND DRUG RESPONSE, METHODS OF DETECTION AND USES THEREOF
摘要 The present invention is based on the discovery of genetic polymorphisms that are associated with cardiovascular disorders, particularly acute coronary events such as myocardial infarction and stroke, and genetic polymorphisms that are associated with responsiveness of an individual to treatment of cardiovascular disorders with statin. In particular, the present invention relates to nucleic acid molecules containing the polymorphisms, variant proteins encoded by such nucleic acid molecules, reagents for detecting the polymorphic nucleic acid molecules and proteins, and methods of using the nucleic acid and proteins as well as methods of using reagents for their detection.
申请公布号 US2017029888(A1) 申请公布日期 2017.02.02
申请号 US201615168632 申请日期 2016.05.31
申请人 CELERA CORPORATION ;BRISTOL-MYERS SQUIBB COMPANY 发明人 CARGILL Michele;IAKOUBOVA Olga;DEVLIN James J.;TSUCHIHASHI Zenta;SHAW Peter;PLOUGHMAN Lynn Marie;ZERBA Kim E.;RANADE Koustubh;KIRCHGESSNER Todd
分类号 C12Q1/68;A61K31/22 主分类号 C12Q1/68
代理机构 代理人
主权项 1. A method for identifying an individual who has an altered risk for developing a cardiovascular disorder or an altered likelihood of responding to statin treatment, the method comprising detecting a single nucleotide polymorphism (SNP) in any one of the nucleotide sequences of SEQ ID NOS:1-517 and 1035-85,090 in said individual's nucleic acids, wherein the presence of the SNP is correlated with an altered risk for developing a cardiovascular disorder or responding to statin treatment in said individual.
地址 San Clemente CA US